Rhythm Pharmaceuticals gains on report of additional bidder (RYTM:NASDAQ)
· seekingalpha.com
Rhythm Pharmaceuticals jumps on a reported second bidder after AstraZeneca’s near-$10B offer.
Rhythm Pharmaceuticals (RYTM) rose 4.2% amid a report of a second bidder for the biotech company.
One of the world's largest pharmaceutical companies is specul...